Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Miehlke

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Therapeutic Advances in Gastroenterology|June 23, 2011
Should quinolones come first in Helicobacter pylori therapy?Marco Berning, Susanne Krasz, Stephan Miehlke
World Journal of Gastroenterology|August 29, 2006
Eradication of H pylori for the prevention of gastric cancerKarolin Trautmann, Manfred Stolte, Stephan Miehlke
Expert Opinion on Pharmacotherapy|May 3, 2007
Esomeprazole: prevention and treatment of NSAID-induced symptoms and ulcersAndrea Morgner, Stephan Miehlke, Joachim Labenz
Alimentary Pharmacology & Therapeutics|December 28, 2020
Letter: PPIs in EoE-More questions than answersStephan Miehlke, Ulrike von Arnim, Stephen Attwood
World Journal of Gastroenterology|January 21, 2006
Is there an association of microscopic colitis and irritable bowel syndrome--a subgroup analysis of placebo-controlled trialsAhmed Madisch, Birgit Bethke, Manfred Stolte, et al.
Journal of Gastroenterology|December 29, 2004
Use of aerosolized inhaled iloprost in the treatment of portopulmonary hypertensionMichael Halank, Christian Marx, Stephan Miehlke, et al.
Expert Opinion on Investigational Drugs|November 18, 2008
Investigational treatment options in microscopic colitisAhmed Madisch, Andrea Morgner, Manfred Stolte, et al.
Journal of Medical Microbiology|April 6, 2006
Prevalence of Bacteroides and Prevotella spp. in ulcerative colitisKatja Lucke, Stephan Miehlke, Enno Jacobs, et al.
Case Reports in Gastroenterology|October 29, 2013
Induction of eosinophilic esophagitis by sublingual pollen immunotherapyStephan Miehlke, Oral Alpan, Sören Schröder, et al.
Medizinische Klinik (Munich, Germany : 1983)|December 8, 2010
[Modern Helicobacter pylori therapies in times of increasing anti biotic resistance]Marco Berning, Susanne Krasz, Joachim Labenz, et al.
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Therapeutic Advances in Gastroenterology|June 23, 2011
Should quinolones come first in Helicobacter pylori therapy?Marco Berning, Susanne Krasz, Stephan Miehlke
World Journal of Gastroenterology|August 29, 2006
Eradication of H pylori for the prevention of gastric cancerKarolin Trautmann, Manfred Stolte, Stephan Miehlke
Expert Opinion on Pharmacotherapy|May 3, 2007
Esomeprazole: prevention and treatment of NSAID-induced symptoms and ulcersAndrea Morgner, Stephan Miehlke, Joachim Labenz
Alimentary Pharmacology & Therapeutics|December 28, 2020
Letter: PPIs in EoE-More questions than answersStephan Miehlke, Ulrike von Arnim, Stephen Attwood
World Journal of Gastroenterology|January 21, 2006
Is there an association of microscopic colitis and irritable bowel syndrome--a subgroup analysis of placebo-controlled trialsAhmed Madisch, Birgit Bethke, Manfred Stolte, et al.
Journal of Gastroenterology|December 29, 2004
Use of aerosolized inhaled iloprost in the treatment of portopulmonary hypertensionMichael Halank, Christian Marx, Stephan Miehlke, et al.
Expert Opinion on Investigational Drugs|November 18, 2008
Investigational treatment options in microscopic colitisAhmed Madisch, Andrea Morgner, Manfred Stolte, et al.
Journal of Medical Microbiology|April 6, 2006
Prevalence of Bacteroides and Prevotella spp. in ulcerative colitisKatja Lucke, Stephan Miehlke, Enno Jacobs, et al.
Case Reports in Gastroenterology|October 29, 2013
Induction of eosinophilic esophagitis by sublingual pollen immunotherapyStephan Miehlke, Oral Alpan, Sören Schröder, et al.
Medizinische Klinik (Munich, Germany : 1983)|December 8, 2010
[Modern Helicobacter pylori therapies in times of increasing anti biotic resistance]Marco Berning, Susanne Krasz, Joachim Labenz, et al.
Pageof 11